InsidersTradesSigma
Total declarations
Company
▲ Purchases (0 ops.)
▼ Sales (0 ops.)
Insider track record
ExecutiveDisclosed buys
0
Disclosed sells
0
T+90 hit rate
100%
T+90 mean return
+69.2%
Across 2 buy signals with a settled T+90 return. Return basis: close on the day after publication.
Signal history
Discover the complete record of transactions filed by Kenyon Julian Norman, Directeur Scientifique. Officer active across 1 company, notably Propanc Biopharma, Inc.. Cumulatively, 2 reports have been published. History available since 17 August 2021. The latest transaction was filed on 17 August 2021 (Attribution). Regulator: SEC (Form 4). The full history is accessible without signup.
Declarations2 total
3,420,000 shares0Common stock, par value $0.001SEC:0001493152-21-020759:0
3,420,000 shares0Common stock, par value $0.001SEC:0001493152-21-020759
2 of 2 declarations
About Kenyon Julian Norman
Julian Norman Kenyon is the Chief Scientific Officer at Propanc Biopharma, Inc. In this role, he is responsible for the research and development of the company's products. His scientific expertise is essential to support innovation and growth at Propanc.
